Crossmark

Building staff capability, opportunity, and motivation to provide smoking cessation to people with cancer in Australian cancer treatment centres: development of an implementation intervention framework for the Care to Quit cluster randomised controlled trial

Crossref DOI link: https://doi.org/10.1007/s10742-022-00288-6

Published Online: 2022-09-28

Published Print: 2023-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ryan, Annika

Young, Alison Luk

Tait, Jordan

McCarter, Kristen

McEnallay, Melissa

Day, Fiona

McLennan, James

Segan, Catherine

Blanchard, Gillian

Healey, Laura

Avery, Sandra

White, Sarah

Vinod, Shalini

Bradford, Linda

Paul, Christine L. https://orcid.org/0000-0002-0504-5246
Funding

Funding for this research was provided by:

National Health and Medical Research Council (APP1169324)

The University of Newcastle
License Information

Text and Data Mining valid from 2022-09-28

Version of Record valid from 2022-09-28
More Information

Article History

Received: 6 March 2022

Revised: 26 July 2022

Accepted: 12 August 2022

First Online: 28 September 2022

Declarations

:

: SV has received honoraria from Astra Zeneca for participation in educational events. FD have served on an advisory board for Amgen, and received clinical trial support from Bristol Myers Squibb and AstraZeneca. All other authors declare that they have no competing interests.

: This study was performed in line with the principles of the Declaration of Helsinki. Ethics approval was granted by the Hunter New England Human Research Ethics Committee (Reference Number: 2020/ETH02010)7 September 2020. Trial registration: ACTRN12621000154808, date of registration: 15 February 2021.

: Consent relating to this study is not applicable.

Document is current

Any future updates will be listed below